NCIt definition : A fully human IgG1 monoclonal antibody against epidermal growth factor receptor (EGFR)
with potential antineoplastic activity. EGFR is a cell surface receptor tyrosine kinase,
overexpressed on many cancer cells. Zalutumumab selectively binds to and blocks binding
of EGF and transforming growth factor-alpha (TGF-a) to the EGFR receptor, thereby
interfering with cellular signaling, leading to cell growth inhibition and apoptosis
in tumor cells. In addition, zalutumumab also triggers cell lysis mediated through
antibody dependent cellular cytotoxicity (ADCC) in EGFR-expressing cells.;
UNII : DA709Q5020;
CAS number : 667901-13-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 667901-13-5
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;